SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-013197
Filing Date
2017-11-14
Accepted
2017-11-14 16:15:50
Documents
58
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 735554
2 ex31-1.htm EX-31.1 15788
3 ex31-2.htm EX-31.2 16829
4 ex32-1.htm EX-32.1 8071
  Complete submission text file 0001493152-17-013197.txt   3140346

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE mtnb-20170930.xml EX-101.INS 391497
6 XBRL SCHEMA FILE mtnb-20170930.xsd EX-101.SCH 37701
7 XBRL CALCULATION FILE mtnb-20170930_cal.xml EX-101.CAL 44896
8 XBRL DEFINITION FILE mtnb-20170930_def.xml EX-101.DEF 181185
9 XBRL LABEL FILE mtnb-20170930_lab.xml EX-101.LAB 268567
10 XBRL PRESENTATION FILE mtnb-20170930_pre.xml EX-101.PRE 229820
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38022 | Film No.: 171201585
SIC: 2834 Pharmaceutical Preparations